Medical diagnostic:
“Medical diagnostics is a $42 billion industry with 85% of testing performed in centralized lab facilities. This industry is beginning to shift towards a more distributed model that allows doctors to test their patients at the point-of-care and have immediate access to their health information in a more clinically relevant time frame. Inspired by natural nanomachines that perform many sensing functions in living organisms, the LBN is now developing new powerful, inexpensive and easy-to-use medical diagnostic devices that will greatly impact Global Health. Examples include, fluorescent probes for cancer imaging and bio-electrochemical devices for the rapid and easy detection of disease markers directly in whole blood.”